SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-261566
Filing Date
2017-08-18
Accepted
2017-08-18 06:07:34
Documents
5
Period of Report
2017-09-28
Effectiveness Date
2017-08-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d441516ddef14a.htm DEF 14A 307430
2 GRAPHIC g4415161.jpg GRAPHIC 897
3 GRAPHIC g4415162.jpg GRAPHIC 872
4 GRAPHIC g441516g30e94.jpg GRAPHIC 36247
5 GRAPHIC g441516g30s39.jpg GRAPHIC 37513
  Complete submission text file 0001193125-17-261566.txt   407463
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 171040064
SIC: 2834 Pharmaceutical Preparations